Apricus Biosciences, Inc. (Nasdaq: APRI) announced that Takeda Pharmaceuticals International GmbH, the Company's partner in the United Kingdom, has accepted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE